company background image
REC logo

Recordati Industria Chimica e Farmaceutica Informe acción BIT:REC

Último precio

€49.10

Capitalización de mercado

€10.1b

7D

-3.9%

1Y

17.7%

Actualizada

29 Apr, 2024

Datos

Finanzas de la empresa +

Recordati Industria Chimica e Farmaceutica S.p.A.

Informe acción BIT:REC

Capitalización de mercado: €10.1b

Resumen de acción REC

Recordati Industria Chimica e Farmaceutica S.p.A., junto con sus filiales, se dedica a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos en todo el mundo.

REC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health3/6
Dividends4/6

Competidores de Recordati Industria Chimica e Farmaceutica S.p.A.

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Recordati Industria Chimica e Farmaceutica
Historical stock prices
Current Share Price€49.10
52 Week High€53.40
52 Week Low€40.62
Beta0.36
1 Month Change-4.18%
3 Month Change-3.35%
1 Year Change17.66%
3 Year Change5.68%
5 Year Change38.50%
Change since IPO3,679.25%

Noticias y actualizaciones recientes

Recent updates

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Apr 25
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Dividend Will Be Increased To €0.63

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

Apr 23
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Share Price Could Signal Some Risk

If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Apr 08
If EPS Growth Is Important To You, Recordati Industria Chimica e Farmaceutica (BIT:REC) Presents An Opportunity

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Mar 23
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.63

Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 27
Is Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Jan 09
We Think Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Stay On Top Of Its Debt

Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Risks To Shareholder Returns Are Elevated At These Prices For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Nov 12
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.57

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Sep 29
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) Using Too Much Debt?

Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 08
Estimating The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 23
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Jun 05
Does This Valuation Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Imply Investors Are Overpaying?

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Apr 08
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Conservative Accounting Might Explain Soft Earnings

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Apr 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.60

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Mar 19
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has Announced That It Will Be Increasing Its Dividend To €0.60

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Mar 06
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 23
A Look At The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Dec 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Nov 11
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.55

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

Sep 01
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Intrinsic Value Is Potentially 42% Above Its Share Price

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Aug 07
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Jun 03
An Intrinsic Calculation For Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Suggests It's 25% Undervalued

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 16
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

May 02
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Paying Out A Larger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 18
Recordati Industria Chimica e Farmaceutica's (BIT:REC) Shareholders Will Receive A Bigger Dividend Than Last Year

Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Apr 04
Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Increasing Its Dividend To €0.57

Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

Mar 21
Recordati Industria Chimica e Farmaceutica (BIT:REC) Will Pay A Larger Dividend Than Last Year At €0.57

These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Mar 06
These 4 Measures Indicate That Recordati Industria Chimica e Farmaceutica (BIT:REC) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Dec 22
Calculating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Dec 05
Recordati Industria Chimica e Farmaceutica (BIT:REC) Has A Pretty Healthy Balance Sheet

Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Sep 23
Estimating The Intrinsic Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

Sep 05
Is Recordati Industria Chimica e Farmaceutica (BIT:REC) A Risky Investment?

A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Jun 25
A Look At The Fair Value Of Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Jun 07
Here's Why Recordati Industria Chimica e Farmaceutica (BIT:REC) Can Manage Its Debt Responsibly

Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

May 10
Earnings Miss: Recordati Industria Chimica e Farmaceutica S.p.A. Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Mar 11
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) Shares Could Be 34% Above Their Intrinsic Value Estimate

Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Feb 19
Here's What You Should Know About Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) 2.4% Dividend Yield

Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 30
Recordati Industria Chimica e Farmaceutica S.p.A.'s (BIT:REC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Rentabilidad de los accionistas

RECIT PharmaceuticalsMercado IT
7D-3.9%1.9%1.0%
1Y17.7%8.7%19.7%

Rentabilidad vs. Industria: REC superó al sector Italian Pharmaceuticals , que obtuvo un rendimiento del 8.7% el año pasado.

Rentabilidad vs. Mercado: REC obtuvo unos resultados inferiores a los del mercado Italian, que fue del 19.7% el año pasado.

Volatilidad de los precios

Is REC's price volatile compared to industry and market?
REC volatility
REC Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement4.4%
10% most volatile stocks in IT Market7.5%
10% least volatile stocks in IT Market2.7%

Precio estable de las acciones: REC no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de REC (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19264,455Rob Koremanswww.recordati.com

Recordati Industria Chimica e Farmaceutica S.p.A., junto con sus filiales, se dedica a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos en todo el mundo. La empresa opera a través de los segmentos de Especialidades y Atención Primaria y Enfermedades Raras. Su cartera de productos incluye REC 0559, en fase II, para el tratamiento de la queratitis neurotrófica; REC 0545, para la descompensación aguda en las enfermedades de la orina con jarabe de arce; ISTURISA, para el síndrome de Cushing endógeno; y CYSTADROPS, para los depósitos corneales de cistina en pacientes con cistinosis.

Resumen de fundamentos de Recordati Industria Chimica e Farmaceutica S.p.A.

¿Cómo se comparan los beneficios e ingresos de Recordati Industria Chimica e Farmaceutica con su capitalización de mercado?
Estadísticas fundamentales de REC
Capitalización bursátil€10.11b
Beneficios(TTM)€389.21m
Ingresos (TTM)€2.08b

26.0x

Ratio precio-beneficio (PE)

4.9x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de REC
Ingresos€2.08b
Coste de los ingresos€600.76m
Beneficio bruto€1.48b
Otros gastos€1.09b
Beneficios€389.21m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

May 09, 2024

Beneficios por acción (BPA)1.89
Margen bruto71.15%
Margen de beneficio neto18.69%
Ratio deuda/patrimonio106.2%

¿Cómo se ha desempeñado REC a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

2.4%

Rentabilidad actual por dividendo

63%

Ratio de pagos
¿Cuándo hay que comprar REC para recibir un próximo dividendo?
fechas de dividendos de Recordati Industria Chimica e Farmaceutica
Fecha ex dividendoMay 20 2024
Fecha de pago de dividendosMay 22 2024
Días hasta ex dividendo20 days
Días hasta la fecha de pago de dividendos22 days